Literature DB >> 24789704

Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer.

Ji-Hee Kim1, Junhye Kwon1, Hae Won Lee2, Moon Chul Kang2, Hyeon-Joon Yoon1, Seung-Taek Lee3, Jong Ho Park2.   

Abstract

Protein tyrosine kinase 7 (PTK7) is a catalytically inactive receptor tyrosine kinase that is also known as colon carcinoma kinase-4 (CCK-4). Recent reports have shown that PTK7 plays an important role in carcinogenesis, and it is known to be upregulated in gastric, colon and esophageal cancer, as well as in liposarcoma. However, the role of PTK7 in lung cancer has not been investigated. The aim of the present study was to investigate the expression levels and the role of PTK7 in lung cancer. We found that PTK7 expression was downregulated at the mRNA as well as protein levels in human lung squamous cell carcinoma (LSCC). Upon investigation of the functional role of PTK7 in LSCC, we found that overexpression of PTK7 in LSCC cells resulted in inhibition of cell proliferation, invasion and migration. Furthermore, we confirmed that these phenotypic changes are associated with the inactivation of AKT and ERK. Our findings suggest that PTK7 has different oncogenic roles in organs and target tumors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789704     DOI: 10.3892/or.2014.3164

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

1.  18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.

Authors:  Orit Jacobson; Ido D Weiss; Lu Wang; Zhe Wang; Xiangyu Yang; Andrew Dewhurst; Ying Ma; Guizhi Zhu; Gang Niu; Dale O Kiesewetter; Neil Vasdev; Steven H Liang; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2015-08-27       Impact factor: 10.057

2.  PTK7 expression is associated with lymph node metastasis, ALK and EGFR mutations in lung adenocarcinomas.

Authors:  Wei Jiang; Jing He; Bihong Lv; Xiaoxiang Xi; Guangming He; Jingkang He
Journal:  Histol Histopathol       Date:  2019-11-08       Impact factor: 2.303

Review 3.  Oncological Ligand-Target Binding Systems and Developmental Approaches for Cancer Theranostics.

Authors:  Jaison Jeevanandam; Godfred Sabbih; Kei X Tan; Michael K Danquah
Journal:  Mol Biotechnol       Date:  2021-01-09       Impact factor: 2.695

4.  PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.

Authors:  Misun Park; Hyeon-Joon Yoon; Moon Chul Kang; Junhye Kwon; Hae Won Lee
Journal:  Tumour Biol       Date:  2016-08-24

5.  Protein-tyrosine pseudokinase 7 (PTK7) directs cancer cell motility and metastasis.

Authors:  Vladislav S Golubkov; Natalie L Prigozhina; Yong Zhang; Konstantin Stoletov; John D Lewis; Phillip E Schwartz; Robert M Hoffman; Alex Y Strongin
Journal:  J Biol Chem       Date:  2014-07-08       Impact factor: 5.157

6.  Immune-related genes and gene sets for predicting the response to anti-programmed death 1 therapy in patients with primary or metastatic non-small cell lung cancer.

Authors:  Bolin Chen; Min Yang; Kang Li; Jia Li; Li Xu; Fang Xu; Yan Xu; Dandan Ren; Jiao Zhang; Liyu Liu
Journal:  Oncol Lett       Date:  2021-05-19       Impact factor: 3.111

7.  PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.

Authors:  Xiuyun Tian; Liang Yan; Donghai Zhang; Xiaoya Guan; Bin Dong; Min Zhao; Chunyi Hao
Journal:  Oncol Rep       Date:  2016-07-28       Impact factor: 3.906

Review 8.  Ptk7 and Mcc, Unfancied Components in Non-Canonical Wnt Signaling and Cancer.

Authors:  Norris Ray Dunn; Nicholas S Tolwinski
Journal:  Cancers (Basel)       Date:  2016-07-16       Impact factor: 6.639

9.  Characterization of the specific interaction between the DNA aptamer sgc8c and protein tyrosine kinase-7 receptors at the surface of T-cells by biosensing AFM.

Authors:  Michael Leitner; Alexandra Poturnayova; Constanze Lamprecht; Sabine Weich; Maja Snejdarkova; Ivana Karpisova; Tibor Hianik; Andreas Ebner
Journal:  Anal Bioanal Chem       Date:  2017-02-22       Impact factor: 4.142

10.  MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin.

Authors:  Misun Park; Hyeon-Joon Yoon; Moon Chul Kang; Junhye Kwon; Hae Won Lee
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.